Disorders of calcium, phosphorus and magnesium metabolism

Journal of Association of Physicians of India

Volumn 56, Issue AUG, 2008, Pages 613-621

  Ghosh, Amit K ^a   Joshi, Shashank R ^b  

^a MAYO CLINIC   (United States)

^b KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; MAGNESIUM; PHOSPHORUS;

HOSPITALIZATION; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; HYPOPHOSPHATEMIA; HYPOTENSION; METABOLIC DISORDER; METABOLISM; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

CALCIUM; HOSPITALIZATION; HUMANS; HYPERCALCEMIA; HYPERPHOSPHATEMIA; HYPOPHOSPHATEMIA; HYPOTENSION; MAGNESIUM; METABOLIC DISEASES; PHOSPHORUS; RISK FACTORS;

EID: 49249132154     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Bushinsky DA, Monk RD. Electrolyte quintet: Calcium. Lancet 1998;352:306-11.
2. Brown EM, Pollak M, Seidman CE, et al. Calcium-ion-sensing cell-surface receptors. N Engl J Med 1995;333:234-40.
3. Hoenderop JG, Bindels RJ. Epithelial Ca2+ and Mg2+ channels in health and disease. J Am Soc Nephrol 2005;16:15-26.
4. Kumar R. Vitamin D and calcium transport. Kidney Int 1991;40:1177-89.
5. Pollak MR, Seidman CE, Brown EM. Three inherited disorders of calcium sensing. Medicine (Baltimore). 1996 ;75:115-23.
6. Carroll MF, Schade DS. A practical approach to hypercalcemia. Am Fam Physician 2003;67:1959-66.
7. Tfelt-Hansen J, Brown EM. The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit Rev Clin Lab Sci 2005;42:35-70.
8. Budayr AA, Nissenson RA, Klein RF, Pun KK, Clark OH, Diep D, Arnaud CD, Strewler GJ. Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia. Ann Intern Med 1989;111:807-12.
9. Thakker RV. Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 2004;35:275-82.
10. Block GA, Martin KJ, de Francisco AL, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004;350:1516-25.
11. Weisinger JR, Bellorín-Font E. Magnesium and phosphorus. Lancet 1998;352:391-6.
12. Schiavi SC, Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int 2004;65:1-14.
13. Gaasbeek A, Meinders AE. Hypophosphatemia: an update on its etiology and treatment. Am J Med 2005;118:1094-101.
14. ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000;26:345-8.
15. Hebert LA, Lemann J Jr, Petersen JR, Lennon EJ. Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest 1966;45:1886-94.
16. Bellinghieri G, Santoro D, Savica V. Emerging drugs for hyperphosphatemia. Expert Opin Emerg Drugs 2007;12:355-65.
17. Simon DB, Nelson-Williams C, Bia MJ,et. Al . Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996;12:24-30.
18. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996;13:183-8.
19. Müller D, Kausalya PJ, Meij IC, Hunziker W. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: blocking endocytosis restores surface expression of a novel Claudin-16 mutant that lacks the entire C-terminal cytosolic tail. Hum Mol Genet 2006;15:1049-58.
20. Schlingmann KP, Sassen MC, Weber S, et al. Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia. J Am Soc Nephrol 2005;16:3061-9.
21. Porath A, Mosseri M, Harman I, Ovsyshcher I, Keynan A. Dead Sea water poisoning. Ann Emerg Med 1989;18:187-91.
22. Gopalan C, Ramasastri BV, SC Balasubramanian. In: Nutritive Value of Indian Foods, National Institute of Nutrituion. 1989, pp 47-73.